Invasive mold infections | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

52,189 results for “Invasive mold infections”

Basilea Launches Phase 3 Trial for Novel Antifungal Fosmanogepix in Invasive Mold Infections

Zepto Life Technology Receives FDA Breakthrough Device Designation for FungiFlex Mold Panel Liquid Biopsy Test

Basilea's Fosmanogepix Enters Phase 3 for Invasive Candidiasis Treatment

Basilea Receives $30 Million Milestone Payment as Cresemba Antifungal Sales Surge 27% Globally

Basilea Secures $30 Million BARDA Tranche to Advance Fosmanogepix Phase III Program for Invasive Fungal Infections

Basilea Secures $39 Million BARDA Funding to Advance Novel Antifungal Candidates Fosmanogepix and BAL2062

Invasive Fungal Infections Market Poised for Robust Growth by 2036 as Novel Broad-Spectrum Antifungals Advance Through Pipeline

Basilea Announces Portfolio Updates: Cresemba and Zevtera Achieve Key Milestones, Pipeline Progresses

Breakthrough Invasive Fungal Infections Pose Challenges in Hematologic Disorders

Elion Therapeutics Initiates Phase 2 Trial of Turletricin for Invasive Mould Infections

Page 1 of 546